NK-92 cells modified to express a dominant negative TGFβRII also demonstrated insensitivity to TGFβ-mediated suppression in vitro and a capacity to decrease tumor proliferation, reduce lung metastasis, and enhance the survival of mice in a lung cancer model [138]. The gene discussed is TGFB1; the disease is neoplasm.